India Betamethasone Market to grow at a steady rate During the Forecast Period
Growing prevalence of skin
diseases is expected to drive the growth of India betamethasone market.
According to
TechSci Research report, “India
Betamethasone Market By Source (In-house v/s Contract Manufacturing
Organizations), By Type (Betamethasone Dipropionate, Betamethasone Sodium
Phosphate, Betamethasone Valerate), By Form (Cream, Ointment & Lotion,
Injection-Solution, Spray & Foam, Others), By Route of Administration
(Parenteral, Ophthalmic, Topical, Infiltration,
Intra-articular/Intralesional/Intramuscular), By Distribution Channel (Online
v/s Offline), By Application (Eczema, Psoriasis, Dermatitis, Others), By End
User (Hospitals & Clinics v/s Homecare), By Company, By Region, Forecast
& Opportunities, FY2026”, the India betamethasone market
is expected to grow at a steady rate during the forecast period on account of the
supportive government policies and schemes promoting the development of APIs
and drugs. The government of India has announced a production linked scheme
worth Rs 6,940 crores for the development of drugs and API in the country
locally. The government has identified 53APIs which will be indigenously
manufactured in the country. This in turn will help in boosting the status of
local manufacturers coupled with reducing dependency on imports. Additionally,
the sudden outbreak and spread of pandemic COVID-19 and Indo-China border
issues have led to the adoption of China plus one strategy. This strategy is
supporting the other schemes such as the “Make in India” and “Local for Vocal”
schemes announced by the government. Furthermore, betamethasone is a gluco-corticosteroid
which is used in the treatment of various diseases including Crohn’s disease,
Leukemia, Asthma, Skin ailments, among others. This in turn is expected to
increase the demand for the drug thereby positively influencing the market
growth through FY2026. However, side-effects such as muscle weakness, allergic
reactions, increased hair growth, skin irritation, among others associated with
the use of betamethasone can hamper the market growth during the forecast
period.
Browse XX market data
Tables and XX Figures spread through XXX Pages and an in-depth TOC on" India Betamethasone Market"
https://www.techsciresearch.com/report/india-betamethasone-market/5146.html
The India
betamethasone market is segmented based on source, type, form, route of
administration, distribution channel, application, end user, company and
region. Based on form, the market can be categorized into cream, ointment &
lotion, injection-solution, spray & foam and others. The cream segment is
expected to dominate the market because of its cost-effectiveness, easy
availability and patient compliance. The ointment & lotion segment is also
expected to witness significant growth through FY2026. This can be ascribed to
their extensive use in thick lesions. Also, they provide better coating or
covering on the skin as compared to creams, sprays or foams. Based on route of
administration, the market can be fragmented into parenteral, ophthalmic,
topical, infiltration and intra-articular/intralesional/intramuscular. The
topical route of administration is expected to dominate the market during the
forecast period. This can be attributed to the widespread use of the medication
in various skin disorders such as eczema, dermatitis, among others. Also, the
medication is available in the form of creams, sprays or foams and ointment
& lotions.
Envee
Drugs Pvt. Ltd., GlaxoSmithKline Pharmaceuticals Ltd, Dermocare Laboratories
(Guj.) Pvt Ltd, Emson Medichem Pvt. Ltd, Cipla Limited, East West Pharma, Omega
Remedies Pvt Ltd, Moraceae Pharmaceuticals Pvt. Ltd., Micro Labs Ltd, Pharmtak
Ophtalmics Pvt. Ltd. and others are some of the leading players operating in India
betamethasone market. Companies operating in the market are using organic
strategies such as product launches, mergers and acquisitions, new technologies
and customer focus approach to boost their share.
Download
Sample Report @
https://www.techsciresearch.com/sample-report.aspx?cid=5146
Customers can
also request for 10% free customization on this report.
“India betamethasone market is
expected to witness growth during the forecast period on account of the growing
focus of the government in making the country self-sufficient with respect to
API manufacturing and drug development. Additionally, the extensive use of the
medication in various conditions is further expected to fuel the market growth
through FY2026. Also, easy availability and affordability are further expected
to increase the demand for the medication.” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based India management consulting firm.
“India Betamethasone Market By
Source (In-house v/s Contract Manufacturing Organizations), By Type
(Betamethasone Dipropionate, Betamethasone Sodium Phosphate, Betamethasone
Valerate), By Form (Cream, Ointment & Lotion, Injection-Solution, Spray
& Foam, Others), By Route of Administration (Parenteral, Ophthalmic,
Topical, Infiltration, Intra-articular/Intralesional/Intramuscular), By
Distribution Channel (Online v/s Offline), By Application (Eczema, Psoriasis,
Dermatitis, Others), By End User (Hospitals & Clinics v/s Homecare), By
Company, By Region, Forecast & Opportunities, FY2026”, has evaluated the future growth potential of India betamethasone
market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in India betamethasone market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]